Cancer stem cells in osteosarcoma: Recent progress and perspective

References

• Makino S. The role of tumor stem-cells in regrowth of the tumor following drastic applications. Acta Unio Internationalis Contra Cancrum 1959;15:196–8.
   PubMedGoogle Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730–7.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983–8.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, . Identification of human brain tumour initiating cells. Nature 2004;432(7015):396–401.
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, . Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445(7123):111–5.
   PubMed Web of Science ®Google Scholar
• O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445(7123):106–10.
   PubMed Web of Science ®Google Scholar
• Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946–51.
   PubMed Web of Science ®Google Scholar
• Li CW, Heidt DG, Dalerba P, Burant CF, Zhang LJ, Adsay V, . Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030–7.
   PubMed Web of Science ®Google Scholar
• Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, . Significance of CD90(+) cancer stem cells in human liver cancer. Cancer Cell 2008;13:153–66.
   PubMed Web of Science ®Google Scholar
• Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, . Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 2005;7:967–76.
   PubMed Web of Science ®Google Scholar
• Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Ann Rev Cell Dev Biol 2007;23:675–99.
   PubMed Web of Science ®Google Scholar
• Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Mori T, . Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas. Biochem Biophys Res Comm 2007;362:773–8.
   PubMed Web of Science ®Google Scholar
• Shackleton M. Normal stem cells and cancer stem cells: Similar and different. Semin Cancer Biol 2010;20:85–92.
   PubMed Web of Science ®Google Scholar
• Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M. Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study. J Clin Oncol 2005;23:3742–51.
   PubMed Web of Science ®Google Scholar
• Meyers PA, Krailo M, Grier H, Bernstein M. Prospectively planned analysis of data from a phase III study of liposomal muramyltripeptide phosphatidylethanolamine in the treatment of osteosarcoma – Reply. J Clin Oncol 2005;23:6438–9.
   Web of Science ®Google Scholar
• Honoki K. Do stem-like cells play a role in drug resistance of sarcomas? Expert Rev Anticancer Ther 2010;10:261–70.
   PubMed Web of Science ®Google Scholar
• Wicha MS, Liu SL, Dontu G. Cancer stem cells: An old idea – A paradigm shift. Cancer Res 2006;66:1883–90.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414(6859): 105–11.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, . Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 2003;9: 1158–65.
   PubMed Web of Science ®Google Scholar
• Schofield R. Relationship between spleen colony-forming cell and hematopoietic stem-cell-hypothesis. Blood Cells 1978;4:7–25.
   PubMedGoogle Scholar
• Chang PY, Bjornstad KA, Chang E, McNamara M, Barcellos-Hoff MH, Lin SP, . Particle irradiation induces FGF2 expression in normal human lens cells. Radiat Res 2000;154:477–84.
   PubMed Web of Science ®Google Scholar
• Tisty T, Grossfeld GD, Hayward SW, Olumi AF, Cunha GR, Carroll PR. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human prostatic epithelium. Mol Biol Cell 1999;10:351a–a.
   Web of Science ®Google Scholar
• Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, . A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11:69–82.
   PubMed Web of Science ®Google Scholar
• De Toni F, Racaud-Sultan C, Chicanne G, Mansat-De Mas V, Cariven C, Mesange F, . A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 2006;25:3113–22.
   PubMed Web of Science ®Google Scholar
• Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, . VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438(7069):820–7.
   PubMed Web of Science ®Google Scholar
• Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, . Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003;100:15178–83.
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, . Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821–8.
   PubMed Web of Science ®Google Scholar
• Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193–206.
   PubMed Web of Science ®Google Scholar
• Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, Argyle DJ. Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J 2008;175:69–75.
   PubMed Web of Science ®Google Scholar
• Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K, Takakura Y. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 2009;34: 1381–6.
   PubMed Web of Science ®Google Scholar
• Wang L, Park P, Lin CY. Characterization of stem cell attributes in human osteosarcoma cell lines. Cancer Biol Ther 2009;8:543–52.
   PubMed Web of Science ®Google Scholar
• Zhou S. Isolation and identification of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs. J Huazhong Univ Sei Technol (Med Sci) 2010;30:81–4.
   PubMedGoogle Scholar
• Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G, Galderisi U, . Detection and characterization of CD133(+) cancer stem cells in human solid tumours. Plos One 2008;3:e3469.
   PubMed Web of Science ®Google Scholar
• Adhikari AS, Agarwal N, Wood BM, Porretta C, Ruiz B, Pochampally RR, . CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res 2010;70:4602–12.
   PubMed Web of Science ®Google Scholar
• Wu CL, Wei QX, Utomo V, Nadesan P, Whetstone H, Kandel R, . Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res 2007;67:8216–22.
   PubMed Web of Science ®Google Scholar
• Murase M, Kano M, Tsukahara T, Takahashi A, Torigoe T, Kawaguchi S, . Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas. Br J Cancer 2009;101:1425–32.
   PubMed Web of Science ®Google Scholar
• Di Fiore R, Santulli A, Ferrante RD, Giuliano M, De Blasio A, Messina C, . Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J Cell Physiol 2009;219:301–13.
   PubMed Web of Science ®Google Scholar
• Levings PP, McGarry SV, Currie TP, Nickerson DM, McClellan S, Ghivizzani SC, . Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res 2009;69:5648–55.
   PubMed Web of Science ®Google Scholar
• Li HZ, Yi TB, Wu ZY. Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells. BMC Cancer 2008;8:135.
   PubMed Web of Science ®Google Scholar
• Reynolds BA, Rietze RL. Neural stem cells and neurospheres – re-evaluating the relationship. Nat Methods 2005;2:333–6.
   PubMed Web of Science ®Google Scholar
• Kotoula V, Papamichos SI, Lambropoulos AF. Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells 2008;26:290–1.
   PubMed Web of Science ®Google Scholar
• Gillette JM, Gibbs CP, Nielsen-Preiss SM. Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma. In Vitro Cell Dev Biol–Animal 2008;44:87–95.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: Markers and models. Nature Rev Cancer 2005;5:591–602.
   PubMed Web of Science ®Google Scholar
• Bernards R, Weinberg RA. Metastasis genes: A progression puzzle. Nature 2002;418(6900):823.
   PubMed Web of Science ®Google Scholar
• Li F, Tiede B, Massague J, Kang YB. Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res 2007;17:3–14.
   PubMed Web of Science ®Google Scholar
• Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu WP, Giri DD, . Genes that mediate breast cancer metastasis to lung. Nature 2005;436(7050):518–24.
   PubMed Web of Science ®Google Scholar
• Minn AJ, Kang YB, Serganova I, Gupta GP, Giri DD, Doubrovin M, . Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005;115:44–55.
   PubMed Web of Science ®Google Scholar
• Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, . Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313–23.
   PubMed Web of Science ®Google Scholar
• Smith MCP, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, . CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004;64:8604–12.
   PubMed Web of Science ®Google Scholar
• Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432(7015):324–31.
   PubMed Web of Science ®Google Scholar
• Ravandi F, Burnett AK, Agura ED, Kantarjian HM. Progress in the treatment of acute myeloid leukemia. Cancer 2007;110:1900–10.
   PubMed Web of Science ®Google Scholar
• Woodward WA, Sulman EP. Cancer stem cells: Markers or biomarkers? Cancer Metastasis Rev 2008;27:459–70.
   PubMed Web of Science ®Google Scholar
• Honoki K. Do stem-like cells play a role in drug resistance of sarcomas? Expert Rev Anticancer Ther 2010;10:261–70.
   PubMed Web of Science ®Google Scholar
• Song B, Wang YA, Titmus MA, Botchkina G, Formentini A, Kornmann M, . Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells. Molecular Cancer 2010;9:96.
   PubMed Web of Science ®Google Scholar
• Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, . Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009;28:4065–74.
   PubMed Web of Science ®Google Scholar
• Gangemi R, Paleari L, Orengo AM, Cesario A, Chessa L, Ferrini S, . Cancer stem cells: A new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem 2009;16:1688–703.
   PubMed Web of Science ®Google Scholar
• Honoki K, Fujii H, Kubo A, Kido A, Mori T, Tanaka Y, . Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol Report 2010;24:501–5.
   PubMed Web of Science ®Google Scholar
• McMahon AP. More surprises in the Hedgehog signaling pathway. Cell 2000;100:185–8.
   PubMed Web of Science ®Google Scholar
• Clement V, Sanchez P, de Tribolet N, Radovanovic I, Altaba ARI. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007;17:165–72.
   PubMed Web of Science ®Google Scholar
• Watkins DN, Peacock CD. Hedgehog signalling in foregut malignancy. Biochem Pharmacol 2004;68:1055–60.
   PubMed Web of Science ®Google Scholar
• Hirotsu M, Setoguchi T, Sasaki H, Komiya S. Hedgehog pathway is activated in osteosarcoma and cyclopamine prevents osteosarcoma growth by cell cycle regulation. J Bone Mineral Res 2008;23:301–7.
   PubMed Web of Science ®Google Scholar
• Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, . Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006;66:7445–52.
   PubMed Web of Science ®Google Scholar
• Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C, . c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 2006;20:2096–109.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Setoguchi T, Hirotsu M, Sasaki H, Komiya S. Notch pathway is activated in osteosarcoma and inhibitors of gamma-secretase inhibit osteosarcoma growth by cell cycle regulation. J Bone Mineral Res 2008;23:297–301.
   Web of Science ®Google Scholar
• Cai YP, Mohseny AB, Karperien M, Hogendoom PCW, Zhou GY, Cleton-Jansen AM. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol 2010;220:24–33.
   PubMed Web of Science ®Google Scholar
• Sciandra M, Barbieri S, Picci P, Scotlandi K. CD99 inhibits osteosarcoma malignacy by acting through Wnt pathway. Proc Am Assoc Cancer Res Annual Meeting 2009;50:845.
   Google Scholar
• Li G-D, Cai Z-D, Zhang Y-Q, Gong H-Y, Tang H, Zhang Q-L. Gene profiling of MAPK pathway in human osteosarcoma. Zhonghua Zhongliu Zazhi 2009;31:340–5.
   PubMedGoogle Scholar
• Ren TT, Guo W, Peng CL, Lu XC, Yang-Yi. Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway. Cancer Biol Ther 2010;10:251–7.
   PubMed Web of Science ®Google Scholar
• Liu SL, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, . Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66:6063–71.
   PubMed Web of Science ®Google Scholar
• Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, . A clinical and experimental-study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991;78:1413–9.
   PubMed Web of Science ®Google Scholar
• Haydon RC, Zhou L, Feng T, Breyer B, Cheng HW, Jiang W, . Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 2002;8:1288–94.
   PubMed Web of Science ®Google Scholar
• Charafe-Jauffret E, Monville F, Ginestier C, Dontu G, Birnbaum D, Wicha MS. Cancer stem cells in breast: Current opinion and future challenges. Pathobiology 2008; 75:75–84.
   PubMed Web of Science ®Google Scholar